Ereska (ketamine intranasal) / Seelos Therap 
Welcome,         Profile    Billing    Logout  
 7 Diseases   3 Trials   3 Trials   44 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ereska (ketamine intranasal) / Seelos Therap
NCT05417074: Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Not yet recruiting
2
10
US
Placebo, SLS-002, Intranasal Racemic Ketamine, Standard of care
Johns Hopkins University, Seelos Therapeutics, Inc.
Depression, Suicidal Behavior, Suicidal Ideation
03/23
08/23
NCT04669665: A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Hourglass Oct 2022 - Mar 2023 : Pivotal data from trial in patients with major depressive disorder at imminent risk of suicide
Checkmark First data from trial for adults with major depressive disorder at imminent risk of suicide
May 2021 - May 2021: First data from trial for adults with major depressive disorder at imminent risk of suicide
Completed
2
164
US
SLS-002, Ketamine hydrochloride, Placebo, Standard of care, Intranasal device
Seelos Therapeutics, Inc.
Depressive Disorder, Major, Suicidal
06/23
07/23
NCT06816433: Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Not yet recruiting
2
200
US
Intervention D SLS-002, Ketamine, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Recruiting
2
800
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo, Intervention D SLS-002, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ereska (ketamine intranasal) / Seelos Therap
NCT05417074: Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Not yet recruiting
2
10
US
Placebo, SLS-002, Intranasal Racemic Ketamine, Standard of care
Johns Hopkins University, Seelos Therapeutics, Inc.
Depression, Suicidal Behavior, Suicidal Ideation
03/23
08/23
NCT04669665: A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Hourglass Oct 2022 - Mar 2023 : Pivotal data from trial in patients with major depressive disorder at imminent risk of suicide
Checkmark First data from trial for adults with major depressive disorder at imminent risk of suicide
May 2021 - May 2021: First data from trial for adults with major depressive disorder at imminent risk of suicide
Completed
2
164
US
SLS-002, Ketamine hydrochloride, Placebo, Standard of care, Intranasal device
Seelos Therapeutics, Inc.
Depressive Disorder, Major, Suicidal
06/23
07/23
NCT06816433: Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Not yet recruiting
2
200
US
Intervention D SLS-002, Ketamine, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Recruiting
2
800
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo, Intervention D SLS-002, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26

Download Options